Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127050941 | 12705094 | 1 | I | 20160809 | 20160831 | 20160831 | PER | US-ASTRAZENECA-2016SE86872 | ASTRAZENECA | 2.00 | YR | M | Y | 0.00000 | 20160901 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127050941 | 12705094 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 10.0MG UNKNOWN | U | U | 21153 | 10 | MG | TABLET | |||||
| 127050941 | 12705094 | 2 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127050941 | 12705094 | 1 | Gastric disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127050941 | 12705094 | Diarrhoea | |
| 127050941 | 12705094 | Eczema | |
| 127050941 | 12705094 | Intentional product misuse | |
| 127050941 | 12705094 | Mass | |
| 127050941 | 12705094 | Medication residue present | |
| 127050941 | 12705094 | Nasal oedema | |
| 127050941 | 12705094 | Rash | |
| 127050941 | 12705094 | Secretion discharge |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |